Gastroenterology · Acibadem Fulya Hospital, İstanbul Prof. Dr. Oya Yönal
✓ Medically verified profileProf. Dr. Oya Yönal
Prof. Dr. Oya Yönal is a gastroenterologist at Acibadem Fulya Hospital in İstanbul. She treats inflammatory bowel disease, including Crohn's disease and ulcerative colitis, liver, biliary tract and pancreatic diseases, hepatitis, malabsorption, and hemorrhoidal and anorectal disorders, and performs endoscopy, gastroscopy and esophagoscopy. She consults in Turkish and English and offers video consultations for international patients.
Accepting international patientsAbout Prof. Dr. Oya Yönal
Prof. Dr. Oya Yönal is a gastroenterologist at Acibadem Fulya Hospital in İstanbul, where she works in the Gastroenterology unit. With more than 25 years in medicine, she cares for adults with conditions of the digestive system, including inflammatory bowel disease, liver, biliary tract and pancreatic diseases, malabsorption, and hemorrhoidal and anorectal disorders. Her subspecialty area is the treatment of hemorrhoids and anorectal diseases.
Dr. Yönal graduated from İstanbul University Faculty of Medicine in 2001 and completed her Internal Medicine training at İstanbul University İstanbul Faculty of Medicine in 2006, having worked there as a research assistant from 2001 to 2006. She then trained in Gastroenterology at Marmara University Faculty of Medicine, where she was a research assistant and specialist between 2007 and 2010, completing her gastroenterology training in 2010. From 2011 she worked in the Gastroenterology department of Memorial Şişli Hospital, first as a specialist, from 2014 as an associate professor and from 2020 as a professor. She joined Acibadem Healthcare Services in 2020. She is a member of the Inflammatory Bowel Diseases Association, ECCO (European Crohn’s and Colitis Organisation), the Turkish Liver Research Association, the Turkish Liver Foundation and the Turkish Gastroenterology Association, where she serves as an İstanbul Branch Board Member. Her published work includes studies on inflammatory bowel disease and ulcerative colitis, as well as on nonalcoholic fatty liver disease and noninvasive assessment of liver fibrosis.
Clinical focus
A central part of Dr. Yönal’s practice is inflammatory bowel disease, including the treatment of Crohn’s disease and ulcerative colitis. Care for these conditions typically involves diagnosis, assessment of disease activity and planning of long-term medical management, adjusted to the individual patient’s course. She performs endoscopic procedures, including endoscopy, gastroscopy and esophagoscopy, which are used to examine the upper digestive tract and to support diagnosis.
Her practice also covers liver diseases, including hepatitis, as well as biliary tract diseases and pancreatic diseases. She evaluates patients with malabsorption and treats hemorrhoidal and anorectal disorders. The choice of investigations and treatment depends on the individual findings, and options are discussed with the patient after clinical assessment.
How Dr. Yönal works with international patients
Dr. Yönal consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as endoscopy and pathology results, laboratory findings, MRI, CT or ultrasound reports, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the possible options. Video consultations are available for international patients who wish to discuss their situation before traveling or as part of follow-up.
What Dr. Yönal treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Areas of practiceTreatment of hemorrhoids and anorectal diseases
Conditions treated
- Crohn’s disease treatment
- Inflammatory bowel disease
- Pancreatic diseases
- Liver diseases
- Biliary tract diseases
- Hepatitis
- Malabsorption
- Hemorrhoidal and anorectal disorders
Procedures performed
Education, career and memberships
Education & training
Education
- 2010Marmara University Faculty of Medicine Gastroenterology
- 2006İstanbul University İstanbul Faculty of Medicine Internal Medicine
- 2001İstanbul University Faculty of Medicine
Career
Professional Experience
- 2020Acıbadem Healthcare Services
- 2020GelişimUniversity / Memorial Şişli Hospital / Gastroenterology / Prof. Dr.
- 2014Memorial Şişli Hospital / Gastroenterology / Associate Professor Dr.
- 2011–2014Memorial Şişli Hospital / Gastroenterology / Specialist Dr.
- 2007–2010Marmara University Faculty of Medicine / Gastroenterology / Research Assistant / Specialist Dr.
- 2001–2006İstanbul University Faculty of Medicine / Internal Medicine / Research Assistant
Memberships
Professional Memberships
- Inflammatory Bowel Diseases Association
- ECCO (European Crohn''s and Colitis Organisation)
- Turkish Liver Research Association
- Turkish Gastroenterology Association (İstanbul Branch Board Member)
- Turkish Liver Foundation
Selected publications
Selected Publications
- No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subiects Türk J Gastroenterol (ISI),Vol 25,639- 43pp, 2014 Yonal O, Eren F, Yilmaz Y, Atug Ö, Över HEL
- Primary malignant melanoma of the esophagus. Case Reports in Gastroenterology (ISI), Vol. 7, 272-6 pp., 2013 Yonal O, ibrisim D, Songur Y, Cakaloglu Y, Tuncer K, Kirimlioglu H, Ozdil S.
- Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis Açta Gastroenterologica Belgica (ISI). Vol. 75,240-4 pp.,2012 Yilmaz Y, Yonal O, Deyneli O, Celikel CA, Kalayci C, Duman DG.
- Should maintenance therapy be performed in ulcerative proctitis? How long should it be continued? Turkish Journal of Gas t roentero 1 ogy (ISf f Ci 11 23, 21-4 pp., 2012 Yönal O, Hatemi G, Kaymakoglu S.
- Do anti-TNF agents and combination treatment increase pöstoperative complication risk? Turkish Journal of GastroenterologyflSD. Vol. 23, 25-9 pp., 2012 Yönal O, Hatemi G, Hamzaoğlu Ö.
- Serum galectin-3 levels in patients with nonalcoholic fatty liver disease Clinical Biochemistry (ISI), Vol. 44, 955-8 pp.,2011 Yilmaz Y, Eren F, Kurt R, Yonal O, Polat Z, Senates E, Bacha M, Imeryuz N
- Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity Journal of Crohn?s and Colitis aSF). Vol. 5,402-6 pp.,2011 Yilmaz Y, Yonal O, Eren F, Atug O, Över Hamzaoglu H
- Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease Atherosclerosis(ISI), Vol. 217,125-9 pp.,2011 Yilmaz Y, Kurt R, Gurdal A, Alahdab YO, Yonal O, Senates E, Polat N, Eren F, Imeryuz N, Oflaz H.
- Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease Disease Markers (ISI), Vol. 31, 205-10 pp., 2011 Yilmaz Y, Eren F, Yonal O, Polat Z, Bacha M, Kurt R, Ozturk O, Avsar E.
- Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver liver disease. Hepatitis Monthlv (ISIT Vol. 11, 103-6 pp.,2011 Yilmaz Y, Yonal O, Kurt R, Bayrak M, Aktas B, Ozdogan O

